Effects of a Researcher-Designed Diabetes Self-Management App on Self-Management Obstacles, Self-Efficacy, and Physiological Indicators in Type 2 Diabetes (Application)
2026年8月28日 更新者：SZU-YI WANG、Fu Jen Catholic University Hospital
Construction and Evaluation of a Self-management APP for Effectiveness in Self-Management, Self-Efficacy, and Metabolic Indicators of Patients With Type 2 Diabetes.
This study aims to evaluate the effectiveness of a self-developed diabetes self-management mobile application on disease self-management outcomes among individuals with type 2 diabetes.
研究概览
研究类型
介入性
注册 (估计的)
80
阶段
- 不适用
参与标准
研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
不
描述
Inclusion Criteria:
- Diagnosed with type 2 diabetes for more than 6 months and Hemoglobin A1c (HbA1c) > 7.5%.
- Having diabetes self-management obstacles.
- Aged 18 years or older.
- Conscious and able to communicate.
- Having a smartphone with internet access.
- Willing to participate in the study and provide written informed consent.
Exclusion Criteria:
- Gestational diabetes mellitus.
- Currently taking steroid medications.
- Having a severe infection requiring hospitalization within the past 6 months.
- Unable to perform self-care independently.
- Having participated in or currently participating in an educational program of a similar nature.
学习计划
本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。
研究是如何设计的？
设计细节
- 主要用途：卫生服务研究
- 分配：随机化
- 介入模型：并行分配
- 屏蔽：单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
无干预：Basic self-management mobile application use.
Participants in the control group will receive routine diabetes care and use the basic functions of the diabetes self-management mobile application.
The basic app functions include self-recording of blood glucose, medication, diet, physical activity, and related health information.
Participants in this group will not receive additional video-based health education or multidisciplinary team care through the application.
|
|
|
实验性的：Enhanced diabetes self-management mobile application use.
Participants in the intervention group will receive routine diabetes care and access to an enhanced diabetes self-management mobile application, which includes basic self-management recording functions, video-based health education, and multidisciplinary team care to support diabetes self-management.
|
Participants in the intervention group will receive routine diabetes care and use the enhanced diabetes self-management mobile application.
In addition to the basic self-management recording functions, the intervention group will receive video-based health education and multidisciplinary team care through the application.
The multidisciplinary team may include healthcare professionals such as physicians, nurses, dietitians, and pharmacists, who provide diabetes-related guidance to support daily self-management, self-efficacy, and metabolic control.
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Diabetes management self-efficacy
大体时间：Baseline, 3 months, and 6 months.
|
|
Baseline, 3 months, and 6 months.
|
|
Diabetes self-management obstacles
大体时间：Baseline, 3 months, and 6 months.
|
Diabetes self-management obstacles will be measured using the Chinese Version of the Diabetes Obstacles Questionnaire-Short Form (CDOQ-S).
Each item is rated on a 5-point Likert scale, ranging from 1 to 5. The items are negatively scored, and higher scores indicate greater obstacles in diabetes self-management.
|
Baseline, 3 months, and 6 months.
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
HbA1c
大体时间：Baseline, 3 months, and 6 months
|
Glycated hemoglobin (HbA1c) will be measured using laboratory blood tests and reported as a percentage (%)
|
Baseline, 3 months, and 6 months
|
|
Fasting plasma glucose
大体时间：Baseline, 3months, and 6months
|
Fasting plasma glucose will be measured using laboratory blood tests and reported in milligrams per deciliter (mg/dL).
|
Baseline, 3months, and 6months
|
|
Triglycerides
大体时间：Baseline, 3months, and 6 months
|
Serum triglyceride levels will be measured using laboratory blood tests and reported in milligrams per deciliter (mg/dL).
|
Baseline, 3months, and 6 months
|
|
Total cholesterol
大体时间：Baseline, 3 months, and 6 months.
|
Serum total cholesterol levels will be measured using laboratory blood tests and reported in milligrams per deciliter (mg/dL).
|
Baseline, 3 months, and 6 months.
|
|
LDL
大体时间：Baseline, 3 months, and 6 months.
|
Serum low-density lipoprotein cholesterol will be measured using laboratory blood tests and reported in milligrams per deciliter (mg/dL).
|
Baseline, 3 months, and 6 months.
|
|
HDL
大体时间：Baseline, 3 months, and 6 months.
|
Serum high-density lipoprotein cholesterol will be measured using laboratory blood tests and reported in milligrams per deciliter (mg/dL).
|
Baseline, 3 months, and 6 months.
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (估计的)
2026年9月1日
初级完成 (估计的)
2028年7月31日
研究完成 (估计的)
2028年7月31日
研究注册日期
首次提交
2026年8月24日
首先提交符合 QC 标准的
2026年8月28日
首次发布 (实际的)
2026年8月31日
研究记录更新
最后更新发布 (实际的)
2026年8月31日
上次提交的符合 QC 标准的更新
2026年8月28日
最后验证
2026年8月1日
更多信息
与本研究相关的术语
其他研究编号
- FJUH114464
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.